Quantcast

Health Care Sector Update for 09/15/2016: XNCR,AERI,GBSN


Shutterstock photo

Top Health Care Stocks

JNJ +0.78%

PFE +0.79%

MRK +0.92%

ABT +1.86%

AMGN +1.68%

Health care stocks were surging today, with the NYSE Health Care Index holding on to a 1.0% gain while shares of health care companies in the S&P 500 were up more than 1.2% as a group.

In company news, Xencor ( XNCR ) rallied Thursday, with shares of the biopharmaceutical company climbing to an all-time high today after saying it has begun dosing patients in a second early-stage trial of its XmAb7195 product candidate to treat certain allergic diseases.

Complete data results from Phase Ia testing found XmAb7195 was generally well tolerated, and induced rapid and extensive depletion of serum IgE - an antibody that produces the immune response in patients - at all doses tested, including in high-IgE subjects. Xencor expects to report interim data from the latest trial next year.

XNCR shares were up slightly nearly 3% at $24.00 each, retrenching somewhat following an earlier 5% advance to a best-ever $24.55 a share.

In other sector news,

(+) AERI, Roclatan drug candidate meets primary efficacy endpoint during Phase III testing, with the potential glaucoma therapy demonstrating statistical superiority over the market-leading latanoprost eye medication.

(-) GBSN, Nasdaq stock market warns the company's stock could be delisted unless it can increase its share price above the stock exchange's $1 minimum.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.



This article appears in: Investing , US Markets
Referenced Symbols: XNCR , AERI ,



More from MT Newswires

Subscribe






MT Newswires
Contributor:

MT Newswires

Market News, Commodities










Research Brokers before you trade

Want to trade FX?